Benjamin J. Kerman
7 Papers
59 Citations
Benjamin J. Kerman is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience.
Peter Moyer,James A. Feldman,Jon Levine,Joni R. Beshansky,Harry P. Selker,Brien A. Barnewolt,David F.M. Brown,Joseph P. Cardoza,Shamai A. Grossman,Alice K. Jacobs,Benjamin J. Kerman,Carey Kimmelstiel,Richard S. Larson,Douglas W. Losordo,Mark D. Pearlmutter,Charles N. Pozner,Alberto Ramirez,Kenneth Rosenfield,Thomas J. Ryan,Richard D. Zane,Christopher P. Cannon +20 more
TL;DR: The history of the Boston EMS STEMI Triage Plan and Treatment Registry is described and the need for other EMS systems to develop a systematic approach to patients with STEMI is suggested.
61
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care.
Jason L. Vassy,Charles A. Brunette,Matthew S. Lebo,Katharine MacIsaac,Thomas Yi,Morgan Danowski,Nicholas V.J. Alexander,Mark P. Cardellino,Kurt D. Christensen,Manish Gala,Robert C. Green,Elizabeth J. Harris,Natalie E Jones,Benjamin J. Kerman,Peter Kraft,Preetika Kulkarni,Anna C.F. Lewis,Steven A. Lubitz,Pradeep Natarajan,Ashley Antwi +19 more
TL;DR: The Genomic Medicine at Veterans Affairs (GenoVA) Study is addressing three main challenges to the clinical implementation of PRS in preventive care: defining and determining their clinical utility, implementing them in time-constrained primary care settings, and countering their potential to exacerbate healthcare disparities.
8
Performance of EHR classifiers for patient eligibility in a clinical trial of precision screening.
Nicholas V.J. Alexander,Charles A. Brunette,Eric T. Guardino,Thomas Yi,Benjamin J. Kerman,Katharine MacIsaac,Elizabeth J. Harris,Ashley Antwi,Jason L. Vassy +8 more
TL;DR: The Genomic Medicine at VA (GenoVA) Study as mentioned in this paper is a pragmatic trial of polygenic risk score testing enrolling patients without known diagnoses of 6 common diseases: atrial fibrillation, coronary artery disease, type 2 diabetes, breast cancer, colorectal cancer, and prostate cancer.
2
Primary care physician use of patient race and polygenic risk scores in medical decision-making.
Benjamin J. Kerman,Charles A. Brunette,Elizabeth J. Harris,Ashley Antwi,Amy A. Lemke,Jason L. Vassy +5 more
TL;DR: Despite advances in precision risk stratification, physicians will likely continue to use patient race implicitly or explicitly in medical decision-making, and that impact varies by patient race.
Patient perspectives of a multidisciplinary Pharmacogenomics clinic.
Lindy Maska,Roseann S. Donnelly,Benjamin J. Kerman,Allison Cirino,Elizabeth Fieg +4 more